Revolution Medicines

Senior Director, Field HEOR

Remote (United States) · Director · Full-time

Sponsorship not specified$259k-$285kDetected 1 day ago

CompliancePatient CareResearchLeadershipCommunication

About the role

Provides RWE & access expertise & leadership through appropriate cross-functional teams aligned to our therapeutic areas.
Influences HEOR and Medical Affairs leadership to ensure critical RWE / access insights are communicated and embedded into our appropriate TA strategies.
Effectively presents research findings to internal stakeholders to improve internal decision making and to promote wider adoption of research findings.

Develops value evidence materials (i.e., proactive, reactive slide decks, models, etc...) for external facing teams to support access challenges.
Continuously builds a comprehensive understanding of customer data sophistication, use, and willingness to collaborate.

Deep knowledge and experience in managed care, integrated delivery networks, formulary decision-making, payment/access models, U.S. policy and HTA trends.

Minimum 13 years of relevant strategic HEOR experience with an advanced degree in a relevant field (DrPH, PharmD).
Proven ability to independently conduct HEOR research across asset lifecycle.
Experience developing and executing customer research collaborations.
Track record of high impact publications in HEOR/RWE topics and development of value evidence materials for U.S. payers.
Strong written and interpersonal communication skills, with an ability to present complex technical information clearly.
Ability to influence others without direct reporting relationships.
Experience in oncology HEOR and RWE development is highly desirable, especially related to gastrointestinal and thoracic malignancies.
#LI-Remote #LI-VN1
The base pay salary range for this full-time position is listed below.
In addition, some positions may include eligibility to earn commissions/bonus based on company and/or individual performance.
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable.
For additional information, please contact privacy@revmed.com.

$259,000 - $285,000 USD
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.
Base Pay Salary Range

Rev Med Health Economics & Outcomes Research (HEOR) and Real World Evidence (RWE) is expanding their field-based HEOR organization.
Deep expertise in health economics, outcomes research, patient-reported outcomes or related fields in the biotechnology or pharmaceutical industry.
Facilitates and implements real-world research partnership engagements with leading healthcare, academic and payer organizations to co-create value evidence and help drive evidence-based optimal care.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.

This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.